Monopar Therapeutics MNPR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's operating lease ROU assets?
- Monopar Therapeutics (MNPR) reported operating lease ROU assets of $239.88K in Q1 2026.
- How has Monopar Therapeutics's operating lease ROU assets changed year-over-year?
- Monopar Therapeutics's operating lease ROU assets increased by 2535.5% year-over-year, from $9.1K to $239.88K.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.